Featured articles from the journal CHEST®, November 2022

The November issue of CHEST contains 51 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia activities, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“Included in the November issue of the journal CHEST is the latest guideline on Perioperative Management of Antithrombotic Therapy,” says Editor-in-Chief, Peter Mazzone, MD, MPH, FCCP. “An update to the 2012 edition, the new guideline addresses 43 Patients-Interventions-Comparators-Outcomes questions related to the perioperative management of patients who are receiving long-term oral anticoagulant or antiplatelet therapy and require an elective surgery or procedure.”

Also included in the current issue of CHEST:

• Chest Infections

  In original research, “Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19,” results did not support the use of convalescent plasma as a treatment for adults hospitalized with COVID-19. A visual abstract for the research can be viewed here and an animation of the research can be viewed here.

• COPD

“Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy” finds that single-inhaler triple therapy was associated with significant reductions in health care resource use, with consequent cost savings. A visual abstract for the research can be viewed here.

• Education and Clinical Practice

Associated with Long COVID, “Neurovascular Dysregulation and Acute Exercise Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome” finds that pyridostigmine improves aerobic capacity in ME/CFS.

• Sleep

Looking at short-term changes, “Air Pollution and the Effectiveness of Positive Airway Pressure Therapy in Individuals with Sleep Apnea” demonstrated that air pollution, even at the relatively low levels, showed a measurable association with a change in objective PAP treatment effectiveness. A visual abstract for the research can be viewed here.

---

Notes for editors

To view the entire November issue of CHEST journal (volume 162, issue 5), published by Elsevier, visit journal.chestnet.org and follow @journal_CHEST on Twitter for the latest journal news.

Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, PR and Communications Specialist, American College of Chest Physicians (CHEST), at [email protected].

About the journal CHEST^®

The journal CHEST, the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.org.

About the American College of Chest Physicians

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.

Acerca de Elsevier

Elsevier es líder global en información avanzada y soporte para la toma de decisiones. Durante más de un siglo, ha ayudado a avanzar la ciencia y la salud para promover el progreso humano. Apoya a comunidades de investigación académicas y corporativas, médicos, enfermeras, futuros profesionales de la salud y educadores en 170 países, proporcionándoles conocimientos críticos y soluciones innovadoras que combinan contenido científico y médico confiable con tecnologías de IA de vanguardia. Elsevier promueve la inclusión y la sostenibilidad incorporando estos valores en sus productos y cultura. La Elsevier Foundation respalda investigaciones y asociaciones de salud alrededor del mundo.

Elsevier forma parte de RELX, proveedor global de herramientas de análisis y decisión basadas en información para clientes profesionales y de negocios. Para más información, visite www.elsevier.com y síganos en redes sociales: @ElsevierConnect.